MBF President Jack Glaser Is 2007 Vermont Small Business Person of the Year

President and co-founder of MBF Bioscience receives top honors at June 6th event.

Burlington, VT, June 06, 2007: Jack Glaser, president and founder of MBF Bioscience received the Small Business Association’s 2007 Vermont Small Business Person of the Year award in a ceremony and reception at Burlington’s Waterfront Park.

Glaser was selected for his outstanding leadership related to his company’s staying power, employee growth, increase in sales, innovative ingenuity, and contributions to the community.

“It is very gratifying to be recognized for all of MBF’s hard work and effort over the past twenty years. Our company is dedicated to helping researchers in their pursuit of understanding how the brain functions. We are most proud that the results of our customer’s research are of benefit to everyone—leading to more fulfilling and healthy lives. It’s rewarding to be recognized for doing the right things for our employees and customers,“ said Glaser.

Glaser founded MicroBrightField (renamed MBF Bioscience in 2006) with his father, Dr. Edmund M. Glaser in 1987. Their goal was to develop powerful yet affordable microscopy imaging software for the global research community. Today, over 1000 researchers around the world use MBF software. Neurolucida has become the gold standard in neuroanatomical software. Stereo Investigator has become the most widely used software for stereology.

Vermont Governor Jim Douglas, who presented the award at the Burlington waterfront, commented that Vermont needs more entrepreneurs like Jack Glaser and more success stories like MBF Bioscience.

As president of MBF Bioscience, Glaser has grown the company from a desk in his bedroom to a successful Vermont based multinational company. The business occupies a headquarters office in Williston, VT with satellite sales offices in Europe and Japan. MBF has a dedicated and talented staff, including experts in biological research and software development.

MBF Bioscience develops analytical software for biological research. The company’s primary market is the field of neuroscience, where its software is used to research brain development and aging as well as diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.